Fourth, the prognostic role of CD166 expression using multivariate regression analysis in OS, PFS and DFS was analyzed in a small population with CRC; additional large-scale studies are necessary to further validate the clinical outcomes of CD166 expression on CRC patients based on larger sample sizes. This evidence concerns the gene ALCAM and colorectal carcinoma.